Environmental Protection Agency (EPA).
There will be a meeting of the Endocrine Disruptor Methods Validation Advisory Committe (EDMVAC) on April 18 through April 20, 2006, in Washington, DC. This meeting, as with all EDMVAC meetings, is open to the public. Seating is on a first-come basis. The purpose of the meeting is to receive advice and input from the EDMVAC on: Male and Female Pubertals Assay Interlaboratory Studies, EDSP's Applied Approach to Validation, Tier 1 Fish Screen Assay Validation Status, updates on Tier 1 Aromatase Assay, and Tier 1 Steroidogenesis Cell Based H295R Assay.
The meeting will be held on Tuesday, April 18, 2006, from 12:30 p.m. to 6 p.m.; Wednesday, April 19, 2006, from 8:30 a.m. to 5:30 p.m.; and Thursday, April 20, 2006, 8 a.m. to 1:30 p.m., eastern standard time. Request to make public comments at the meeting must be received by EPA on or before April 14, 2006.
To request accommodation of a disability, please contact the person listed under FOR FURTHER INFORMATION CONTACT, preferably at least 10 days prior to the meeting, to give EPA as much time as possible to process your request.
The meeting will be held at the Capital Hilton Hotel and Conference Center, 1001 16th St., NW., Washington, DC 20036; telephone number: (202) 393-1000; e-mail: http://www.hilton.com.
Requests to make public comments at the meeting may be submitted by e-mail, telephone, fax, or through hand delivery/courier. Follow the detailed instructions as provided in Unit I. of the SUPPLEMENTARY INFORMATION.
Comments may be submitted electronically, by fax, or through hand delivery/courier. Follow the detailed instructions as provided in Unit I. of the SUPPLEMENTARY INFORMATION.Start Further Info
FOR FURTHER INFORMATION CONTACT:
For general information or for information on access or services for individuals with disabilities: William Wooge, Designated Federal Official (DFO), Office of Science Coordination and Policy (7203M), Office of Prevention, Pesticides and Toxic Substances (OPPTS), Environmental Protection Agency, 1200 Pennsylvania Ave., NW., Washington, DC 20460-0001; telephone number: (202) 564-8476; fax number: (202) 564-8482; e-mail address: firstname.lastname@example.org.End Further Info End Preamble Start Supplemental Information
I. General Information
A. Does this Action Apply to Me?
This action is directed to the public in general. This action may, however, be of interest if you produce, manufacture, use, consume, work with, or import pesticide chemicals and other substances. To determine whether you or your business may have an interest in this notice you should carefully examine section 408(p) of the Federal Food, Drug, and Cosmetic Act (FFDCA), as amended by the Food Quality Protection Act (FQPA) of 1996 (Public Law 104-170), 21 U.S.C. 346a(p), and amendments to the Safe Drinking Water Act (SDWA) (Public Law 104-182), 42 U.S.C. 300j-17. Since other entities may also be interested, the Agency has not attempted to describe all the specific entities that may be interested in this action. If you have any questions regarding this action, consult the person listed under FOR FURTHER INFORMATION CONTACT. Start Printed Page 15725
B. How Can I Get Additional Information, Including Copies of this Document or Other Related Documents?
1. Docket. EPA has established an official public docket for this action under docket identification (ID) number EPA-HQ-OPPT-2006-0233. The official public docket consists of the documents specifically referenced in this action, any public comments received, and other related information. Although a part of the official docket, the public docket does not include Confidential Business Information (CBI) or other information whose disclosure is restricted by statute. The official public docket is the collection of materials that are available for public viewing at the EPA Docket Center, Rm. B102-Reading Room, EPA West, 1301 Constitution Ave., NW., Washington, DC. The EPA Docket Center is open from 8:30 a.m. to 4:30 p.m., Monday through Friday, excluding legal holidays. The EPA Docket Center Reading Room telephone number is (202) 566-1744, and the telephone number for the OPPT Docket, which is located in the EPA Docket Center, is (202) 566-0282.
2. Electronic access. You may access this Federal Register document electronically through the EPA Internet under the “Federal Register” listings at http://www.epa.gov/fedrgstr/. A meeting agenda, a list of EDMVAC members and information from previous EDMVS meetings are available electronically, from the EPA Internet Home Page at http://www.epa.gov/scipoly/oscpendo/.
An electronic version of the public docket is available through EPA's electronic public docket and comment system, EPA Dockets. You may use EPA Dockets at http://www.regulations.gov/ to submit or view public comments, access the index listing of the contents of the official public docket, and to access those documents in the public docket that are available electronically. Once in the system, select “Advance search,” select “Docket search,” then key in the appropriate docket ID number.
C. How Can I Request to Give Comments in Person at the Meeting?
You may submit a request to make public comments at the meeting through e-mail, telephone, fax, or hand delivery/courier. We would normally accept requests by mail, but in this time of delays in delivery of government mail due to health and security concerns, we cannot assure your request would arrive in a timely manner. Do not submit any information in your request that is considered CBI. Your request must be received by EPA on or before April 14, 2006. To ensure proper receipt by EPA, it is imperative that you identify docket ID number EPA-HQ-OPPT-2006-0233 in the subject line on the first page of your request.
In accordance with the Federal Advisory Committee Act (FACA), the public is encouraged to submit written comments on the topic of this meeting. The EDMVAC will have a period available during the meeting for public comment. It is the policy of the EDMVAC to accept written public comments of any length, and to accommodate oral public comments whenever possible. The EDMVAC expects that public statements presented at its meeting will be on the meeting topic and not be repetitive of previously submitted oral or written statements.
1. Electronically. If you submit an electronic request to make public comments at the meeting or comments as prescribed in this unit, EPA recommends that you include your name, mailing address, and an e-mail address or other contact information in the body of your request or comment. Also include this contact information on the outside of any disk or CD ROM you submit, and in any cover letter accompanying the disk or CD ROM. This ensures that you can be identified as the submitter of the request or comment and allows EPA to contact you in case EPA cannot read your request or comment due to technical difficulties or needs further information on the substance of your request or comment. EPA's policy is that EPA will not edit your request or comment, and any identifying or contact information provided in the body of a request or comment will be included as part of the request or comment that is placed in the official public docket, and made available in EPA's electronic public docket. If EPA cannot read your request or comment due to technical difficulties and cannot contact you for clarification, EPA may not be able to consider your request or comment.
i. EPA Docket. You may use EPA's electronic public docket http://www.regulation.gov/, and follow the online instructions for submitting materials. Once in the system, select “Advance search,” select “Docket search,”and then key in docket ID number EPA-HQ-OPPT-2006-0233. The system is an “anonymous access” system, which means EPA will not know your identity, e-mail address, or other contact information unless you provide it in the body of your request.
ii. E-mail. Requests to make public comments at the meeting or written comments may be sent by e-mail to email@example.com, Attention: Docket ID Number EPA-HQ-OPPT-2006-0233. In contrast to EPA's electronic public docket, EPA's e-mail system is not an “anonymous access” system. If you send an e-mail request directly to the docket without going through EPA's electronic public docket, EPA's e-mail system automatically captures your e-mail address. E-mail addresses that are automatically captured by EPA's e-mail system are included as part of the request that is placed in the official public docket, and made available in EPA's electronic public docket.
iii. Disk or CD ROM. You may submit comments on a disk or CD ROM by hand delivery, courier, or package service, such as Federal Express, to the person listed under FOR FURTHER INFORMATION CONTACT. These electronic submissions will be accepted in WordPerfect or ASCII file format. Avoid the use of special characters and any form of encryption. Do not submit any disk or CD ROM through the mail. Disks and CD ROMs risk being destroyed when handled as Federal Government mail.
2. Telephone or fax. Telephone or fax your request to participate at the meeting to the person listed under FOR FURTHER INFORMATION CONTACT.
3. By hand delivery or courier. Deliver your comments to: OPPT Document Control Office (DCO) in EPA East Bldg., Rm. 6428, 1201 Constitution Ave., Washington, DC. Attention: Docket ID Number EPA-HQ-OPPT-2006-0233. The DCO is open from 8 a.m. to 4 p.m., Monday through Friday, excluding legal holidays. The telephone number for the DCO is (202) 564-8930.
In 1996, through enactment of FQPA, which amended the FFDCA, Congress directed EPA to develop a screening program, using appropriate validated test systems and other scientifically relevant information, to determine whether certain substances may have an effect in humans that is similar to an effect produced by a naturally occurring estrogen, or such other endocrine effect as the Administrator may designate. In 1996, EPA chartered a scientific advisory committee, the Endocrine Disruptor Screening and Testing Advisory Committee (EDSTAC), under the authority of FACA, to advise it on establishing a program to carry out Congress' directive. EDSTAC recommended a multi-step approach including a series of screens (Tier 1 screens) and tests (Tier 2 tests) for determining whether a chemical substance may have an effect similar to that produced by naturally occurring hormones. EPA adopted almost all of Start Printed Page 15726EDSTAC's recommendations in the program that it developed, the Endocrine Disruptor Screening Program (EDSP), to carry out Congress' directive.
EPA is in the process of developing and validating the screens and tests that EDSTAC recommended for inclusion in the EDSP. In carrying out this validation exercise, EPA is working closely with the Interagency Coordinating Committee for the Validation of Alternate Methods (ICCVAM) and other validation groups, as appropriate. EPA also is working closely with the Organization for Economic Cooperation and Development's (OECD) Endocrine Disruptors Testing and Assessment Task Force to validate and harmonize endocrine screening tests of international interest.
Finally, to ensure that EPA has the best and most up-to-date advice available regarding the validation of the screens and tests in the EDSP, EPA chartered the Endocrine Disruptor Methods Validation Subcommmittee (EDMVS) of the National Advisory Council for Environmental Policy and Technology (NACEPT). The EDMVS convened nine meetings between October 2001 and December 2003. In 2003, NACEPT recommended EDMVS become an Agency level 1 FACA Committee due to the complexity of the recommendations. The EDMVAC was chartered in 2004. The EDMVAC provides independent advice and counsel to the Agency on scientific and technical issues related to validation of the EDSP Tier 1 screens and Tier 2 tests, including advice on methods for reducing animal use, refining procedures involving animals to make them less stressful, and replacing animals where scientifically appropriate. EDMVAC and previous EDMVS meeting information and corresponding docket numbers are available electronically, from the EPA Internet Home Page at http://www.epa.gov/scipoly/oscpendo/. You may also go to the EPA Docket at http://www.regulations.gov/, and follow the online instructions for submitting materials.
III. Meeting Objectives for the April 18-20, 2006 Meeting
The objectives for the April 18 through April 20, 2006 meeting (docket ID number EPA-HQ-OPPT-2006-0233) are to review and discuss: Aromatase Assay Update (Tier 1), Steroidogenesis Cell Based H295R Assay Update (Tier 1), Male and Female Pubertals Assay Interlaboratory Studies, Fish Screen Assay Validation Status (Tier 1), and EPA's Applied Approach to Validation.
A list of the EDMVAC members and meeting materials are available at http://www.epa.gov/scipoly/oscpendo/ and in the public docket.Start List of Subjects
List of SubjectsEnd List of Subjects Start Signature
Dated: March 21, 2006.
Clifford J. Gabriel,
Director, Office of Science Coordination and Policy.
[FR Doc. E6-4570 Filed 3-28-06; 8:45 am]
BILLING CODE 6560-50-S